See also this year's filing and all EDGAR filings for this company.
PDF Report 0001785530_2023_Werewolf_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001785530, Werewolf Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 140,200,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 8,988,000 |
3 | remainder_Assets | 11,057,000 |
4 | LiabilitiesCurrent | 23,989,000 |
5 | LiabilitiesNoncurrent | 13,919,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 18,696,000 |
9 | ResearchAndDevelopmentExpense | 53,761,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 18,647,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 160,245,000 |
1 | Liabilities | 37,908,000 |
2 | Expenses | 72,457,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 122,337,000 |
5 | NetIncome | -53,810,000 |
6 | ComprehensiveNetIncome | -53,810,000 |
7 | BaseVar | 144,628,500 |
8 | EconomicCapitalRatio | 1.58 |